Publications dans lesquelles il/elle collabore avec Miguel Ángel Martínez García (19)

2024

  1. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

  3. The role of precision medicine in bronchiectasis: emerging data and clinical implications

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 4, pp. 279-293

2022

  1. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  2. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  3. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity

    Biomolecules, Vol. 12, Núm. 10

  4. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

  5. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  2. Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis: A large-cohort study

    Biomedicines, Vol. 9, Núm. 8

  3. Phenotypic clustering in non-cystic fibrosis bronchiectasis patients: The role of eosinophils in disease severity

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 16

  4. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis

    Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434

  5. RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 28-35

  6. Treatment of pulmonary disease of cystic fibrosis: A comprehensive review

    Antibiotics, Vol. 10, Núm. 5

2020

  1. COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective Study

    Chest, Vol. 157, Núm. 4, pp. 824-833

  2. Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664

  3. Impact of pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases

    Journal of Clinical Medicine, Vol. 9, Núm. 12, pp. 1-32

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416